Roche Holding AG

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Regeneron Pharmaceuticals

Both companies are fighting the coronavirus pandemic on multiple fronts. Here's which stock is the better pick for long-term investors.

Better Coronavirus Stock: Regeneron or Roche?

Roche (RHHBY) gets FDA nod to evaluate Actemra plus standard of care in hospitalized adult patients with severe COVID-19 pneumonia.

Roche Gets FDA Approval for Actemra Trials in COVID-19

The anti-inflammatory drug could help patients infected with the novel coronavirus.

Roche Tests Arthritis Drug Actemra for COVID-19 Pneumonia

"No doubt, ideally we would have broader testing, but at the moment, capacities are limited," Roche CEO Severin Schwan said on CNBC's "Squawk Box." "I think this is still a couple of weeks, if not months, out, and the reason is very simple.

Widespread coronavirus testing in US is 'weeks, if not months out,' says CEO of test manufacturer Roche

Shares of Roche Holding AG ROG, -4.30% are down 3% in trading on Monday after the drugmaker said it had received regulatory approval to begin a late-stage clinical trial examining the safety and effectiveness of Actemra, its rheumatoid arthritis treatment, in hospitalized patients with COVID-19 pneumonia.

Roche gets go-ahead from FDA for COVID-19 clinical trial

Automatic Data Processing

Air Products and Chemicals

Caterpillar

Colgate-Palmolive

General Dynamics

Illinois Tool Works

Johnson & Johnson

Kimberly-Clark

Medtronic

PepsiCo

Stryker

My goal is to always provide you with the best evidence based long-term strategies for achieving their your financial goals. The latest economic news surrounding the COVID-19 pandemic is grim.

The 12 Safest Dividend Aristocrats To Buy During This Recession

Bayer AG

FUJIFILM Holdings Corp

Gilead Sciences

Mylan

Sanofi

These drugs could be key to staving off COVID-19 until a vaccine is developed.

All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them

Potential coronavirus treatments from Regeneron, Sanofi, and Gilead Sciences will get more chances to prove themselves effective.

Nonprofit Group Starts Multiple COVID-19 Clinical Studies

Abbott Labs

Thermo Fisher Scientific

The agency hasn't approved any in-home test kits yet.

FDA Warns About Unauthorized Fraudulent COVID-19 Tests

The issue isn't just getting COVID-19 tests produced and distributed -- it's also that there's a limited supply of machines that can process them.

Coronavirus Test Capacity Too Limited for Mass Screening, Warns Roche CEO

Roche (RHHBY) works with the FDA to evaluate the safety and efficacy of rheumatoid arthritis drug, Actemra, in severe COVID-19.

Roche to Evaluate Actemra for Severe COVID-19 Pneumonia

Becton, Dickinson and Co.

Teladoc

Amid the pandemonium associated with coronavirus, we look into four stocks that have the potential to benefit from this outbreak.

4 Potential Gainers Amid Intensifying Coronavirus Fears

Enanta Pharmaceuticals

Eli Lilly

Moderna

Given the urgent need for curing infected COVID-19 patients, we take a look at companies developing drugs/treatments for the same.

Drugs or Vaccines: Which Will Be More Crucial Against Coronavirus?

Shares of Roche Holding AG ROG, +4.16% gained 3.7% in premarket trading on Thursday after the Swiss drugmaker said it plans to run a Phase 3 clinical testing Acterma, its rheumatoid arthritis drug, as a treatment for patients with COVID-19 who have been hospitalized with severe pneumonia.

Roche to test Acterma as a treatment for COVID-19

QIAGEN

Multiple companies have gained regulatory approvals in recent days.

Coronavirus Test-makers Ramp Up Production

Quest Diagnostics

There are several key diagnostic testing laboratory and biotech players whose prospects seem bright on account of rigorous work on developing diagnostic testing for the coronavirus.

Coronavirus Testing Players Gain Momentum: 3 Stocks in Focus

Going by trends seen during the 2008 crisis, Roche Holdings ADR could potentially outperform the broader market, when the current crisis is over. We compare the performance of Roche vis-à-vis the S&P 500 in our interactive dashboard analysis, Roche Holdings ADR Compared with S&P 500.

Roche’s ADR To Outperform Post Coronavirus?

This should accelerate the process of getting more people tested for COVID-19.

FDA Allows States to Approve Their Own Coronavirus Tests

Chubb

Diageo

New Linde PLC

The 10 Best Low-Volatility Blue Chips To Help You Sleep Well At Night

Roche Holding AG (OTC: RHHBY) is shipping COVID-19 test kits approved under emergency use authorization (EUA) by the FDA.

Roche Receives FDA Emergency Approval To Ship 400,000 Coronavirus Test Kits Across US

CVS Health

Labcorp Holdings Inc

Walgreens

The president mentioned many of these companies by name in his news conference and even had their CEOs speak.

Healthcare Stocks Are Surging After Trump's Coronavirus Conference

The President asked that state and local healthcare authorities to do everything in their power to fight the virus.

Trump Declares National Emergency Over Coronavirus

Roche Holding (RHHBY) news for Friday includes an update on testing for the coronavirus from China with approval from the FDA.
The post Roche Holding News: RHHBY Stock Jumps 8% on Faster Coronavirus Test appeared first on InvestorPlace.

Roche Holding News: RHHBY Stock Jumps 8% on Faster Coronavirus Test

The test can produce results in under four hours.

FDA Issues Emergency Use Authorization for Roche's Coronavirus Test

Roche stock surged Friday after the Food and Drug Administration issued an emergency approval for its coronavirus test. The test looks for SARS-CoV-2, the virus that causes Covid-19.

News for Roche Holding AG Stock (RHHBY)